Table 4.
Age adjusted |
Adjusted for age +3 primary confounders |
|||||||
---|---|---|---|---|---|---|---|---|
Outcome | Hypnotic use 5+/week |
Hypnotic use 5+/week |
||||||
HR | χ2** | CI |
HR | χ2** | CI |
|||
Myocardial infarction | 1.35 | 21.7 | 1.19 | 1.53 | 1.02 | 0.05 | 0.89 | 1.15 |
Stroke | 1.35 | 18.1 | 1.17 | 1.54 | 1.09 | 1.5 | 0.95 | 1.25 |
Diabetes | 1.17 | 14.9 | 1.08 | 1.27 | 0.85 | 15.4 | 0.78 | 0.92 |
Breast cancer | 1.11 | 3.7 | 1.00 | 1.22 | 1.12 | 4.7 | 1.01 | 1.24 |
Colon cancer | 0.70 | 6.4 | 0.53 | 0.92 | 0.64 | 9.7 | 0.49 | 0.85 |
Lung cancer | 1.58 | 20.6 | 1.30 | 1.92 | 1.17 | 2.3 | 0.96 | 1.43 |
Colorectal cancer | 0.71 | 6.8 | 0.55 | 0.92 | 0.66 | 10.2 | 0.51 | 0.85 |
Lymphoma | 1.09 | 0.3 | 0.79 | 1.52 | 1.04 | 0.05 | 0.74 | 1.45 |
Melanoma | 1.35 | 5.2 | 1.04 | 1.74 | 1.53 | 10.4 | 1.18 | 1.99 |
Ovary cancer | 0.94 | 0.1 | 0.65 | 1.36 | 0.93 | 0.1 | 0.64 | 1.36 |
*If χ2 ≥ 9.5, p<0.05. If χ2 ≥ 22.7, p<0.0001.
**If χ2 ≥ 3.84, p<0.05. If χ2 ≥ 14.4, p<0.0001.